As a direct application of NEBULA, we performed a cell-level transcriptomic co-expression analysis of APOE, the strongest genetic risk factor of AD, and investigated its cell-type-specific regulatory mechanisms in microglia and astrocytes, both of which are known to abundantly express APOE and to undergo cell activation transitions in the context of AD pathology. Here, APOE is linked to Alzheimer disease.